Brett W. Sperry, M., Yazan Almohtasib, M., Ramy Ghaly, M., Mohammad Abdel Jawad, M., Andrew J. Sauer, M., & Timothy M. Bateman, M. (2025). SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism. Elsevier.
Chicago Style (17th ed.) CitationBrett W. Sperry, MD, MD Yazan Almohtasib, MD Ramy Ghaly, MD Mohammad Abdel Jawad, MD Andrew J. Sauer, and MD Timothy M. Bateman. SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism. Elsevier, 2025.
MLA (9th ed.) CitationBrett W. Sperry, MD, et al. SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism. Elsevier, 2025.
Warning: These citations may not always be 100% accurate.